Valuation : Gland Pharma Limited

Market Cap 480B 5.07B 4.37B 4.1B 3.75B 7B 7.05B 48.47B 18.88B 245B 19.06B 18.64B 790B P/E 2027 *
36.5x
P/E 2028 * 30x
Enterprise Value 442B 4.68B 4.03B 3.78B 3.46B 6.45B 6.5B 44.69B 17.4B 226B 17.57B 17.19B 728B EV / Sales 2027 *
5.9x
EV / Sales 2028 * 5.04x
Free-Float
48.23%
Yield 2027 *
0.7%
Yield 2028 * 0.77%
1 day+1.38%
1 week+1.20%
Current month+0.77%
1 month+12.74%
3 months+30.26%
6 months+70.21%
Current year+68.87%
1 week 2,803
Extreme 2803
2,948
1 month 2,531.1
Extreme 2531.1
3,039.8
Current year 1,573.6
Extreme 1573.6
3,039.8
1 year 1,573.6
Extreme 1573.6
3,039.8
3 years 1,277.8
Extreme 1277.8
3,039.8
5 years 861
Extreme 861
4,179.65
10 years 861
Extreme 861
4,350
Manager TitleAgeSince
Director of Finance/CFO - 2019-09-29
Chief Operating Officer - 2026-04-05
Chief Tech/Sci/R&D Officer - 2026-02-17
Director TitleAgeSince
Chairman 57 2024-06-09
Director/Board Member 71 2018-02-06
Director/Board Member 69 2021-05-16
Date Insider Type Main position Quantity % Market Cap. Importance
2/26/25 Buy 2,800 0.0017%
6/28/24 Sell 1,950 0.0012%
6/28/24 Sell 1,400 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+1.38%+1.20%+54.94%+70.15% 5.01B
-0.17%-1.53%+56.96%+107.47% 1,034B
+1.02%+4.63%+56.22%+73.06% 663B
-0.29%+1.15%+23.25%+78.72% 462B
+2.09%-2.06%+32.28%+38.37% 344B
0.00%+5.36%+27.40%+47.50% 307B
+1.42%+0.26%-0.52%+13.62% 251B
+0.17%+1.49%+56.25%+74.61% 239B
-0.03%+2.13%-17.30%-53.99% 207B
+0.63%+1.30%+33.45%+100.63% 186B
Average +0.76%-0.75%+32.29%+55.01% 369.84B
Weighted average by Cap. +0.57%-0.84%+38.58%+68.38%

Financials

2027 *2028 *
Net sales 74.93B 793M 682M 640M 586M 1.09B 1.1B 7.57B 2.95B 38.29B 2.98B 2.91B 123B 85.84B 908M 781M 733M 671M 1.25B 1.26B 8.67B 3.38B 43.87B 3.41B 3.34B 141B
Net income 13.12B 139M 119M 112M 103M 191M 193M 1.33B 516M 6.7B 521M 510M 21.59B 15.95B 169M 145M 136M 125M 233M 234M 1.61B 628M 8.15B 634M 620M 26.25B
Net Debt -37.45B -396M -341M -320M -293M -546M -551M -3.78B -1.47B -19.14B -1.49B -1.46B -61.64B -47.28B -500M -430M -404M -369M -690M -695M -4.78B -1.86B -24.16B -1.88B -1.84B -77.82B
Logo Gland Pharma Limited
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.
Employees
4,332
Date Price Change Volume
26-09-03 2,907.90 +1.38% 189,288
26-09-02 ₹2,868.40 -0.23% 556,481
26-09-01 ₹2,875.00 -0.37% 257,559
26-08-31 ₹2,885.80 -0.08% 370,779
26-08-28 ₹2,888.00 +0.50% 165,191
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,907.90INR
Average target price
2,856.07INR
Spread / Average Target
-1.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GLAND Stock